Palisade Bio (PALI) EPS (Basic) (2010 - 2026)

Palisade Bio (PALI) posted quarterly EPS (Basic) of -$0.05 for Q1 2026, up 88.97% year-over-year from -$0.03 in Q1 2025, and up 71.42% quarter-over-quarter from -$0.18 in Q4 2025.

Palisade Bio (PALI) EPS (Basic) (2010 - 2026) Analysis & Trends

Palisade Bio (PALI) has reported EPS (Basic) for 17 consecutive years, with -$0.05 the latest figure, recorded in Q1 2026.

  • In Q1 2026, EPS (Basic) rose 88.97% year-over-year to -$0.05; the TTM figure through Mar 2026 stood at -$0.13 (up 95.42% YoY), while the FY2025 annual figure was -$0.81, up 97.56% from the prior year.
  • EPS (Basic) improved to -$0.05 in Q1 2026 per PALI's latest filing, from -$0.18 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.05 in Q1 2026 and bottomed at -$181.71 in Q1 2022.
  • Historically, EPS (Basic) has averaged -$26.36 across 5 years, with a median of -$4.59 in 2024.
  • Annual changes were most pronounced in 2022 — EPS (Basic) soared 96.79% — and 2024, when it jumped 43.54%.
  • Palisade Bio's EPS (Basic) stood at -$65.6 in 2022, then soared by 89.44% to -$6.92 in 2023, then soared by 65.46% to -$2.39 in 2024, then soared by 92.5% to -$0.18 in 2025, then jumped by 71.42% to -$0.05 in 2026.
  • Business Quant data shows PALI's EPS (Basic) at -$0.05 in Q1 2026, -$0.18 in Q4 2025, and -$0.38 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.62
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.59
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.18
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.23
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Palisade Bio 372.94 Mn 247.74 Mn - -0.06

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.06
Mar 31, 2026 -0.05
Dec 31, 2025 -0.18
Sep 30, 2025 -0.38
Jun 30, 2025 -0.58
Mar 31, 2025 -0.47
Dec 31, 2024 -2.39
Sep 30, 2024 -2.32
Jun 30, 2024 -3.32
Mar 31, 2024 -4.59
Dec 31, 2023 -6.92
Sep 30, 2023 -7.76
Jun 30, 2023 -7.93
Mar 31, 2023 -8.13
Dec 31, 2022 -65.60
Sep 30, 2022 -69.21
Jun 30, 2022 -86.62
Mar 31, 2022 -181.71
Dec 31, 2021 -136.78
Sep 30, 2021 -188.53